CEO Mohammad Afshar and VP Computational Technology David Morley will be attending the Genesis 2013 conference in London on 12th December.

Dr Afshar is a panel member for the Developing Oncology Biomarkers: Lessons from other therapeutic areas session. Dr Morley is presenting our WINTHER press release at the Pre-Genesis BioNewsRound awards on Dec 11th.

Now in it’s 13th year, the Genesis conference programme carries a key theme each year to track and address the key challenges in the constantly evolving life sciences industry. In 2013 that focus is on Innovative Strategies to Bridge the R&D Gap in Life Sciences.’